- Brainstem
- DIPG
- Tectum/Cerebellum
- Pilocytic astrocytoma
- Medulloblastoma
- Haemangioblastoma
- Cerebellar liponeurocytoma
- Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)
- Fourth Ventricle
- Medulloblastoma
- Ependymoma
- Choroid Plexus Papilloma
- Rosette forming glioneuronal tumour (RGNT)
- CP Angle
- Nerve sheath
- Vestibular schwannoma
- Non nerve sheath
- Meningioma
- Choroid plexus papilloma
- Dermoid cyst
- Epidermoid cyst
- Arachnoid cyst
- Classification
Tumor Type | WHO Grade | Percentage of All CNS Tumors | Location of Tumor | Imaging Characteristics | 5-Year Overall Survival | Recommended Treatment |
Pilocytic astrocytoma | I | 2.10% | Vermis = hemispheres | Well circumscribed, contrast enhancing; often with cystic formation and mural nodule | 85%–100% | GTR |
Medulloblastoma | IV | 1.50% | Hemispheres > vermis | Variable definition, variable enhancement; may have cystic or necrotic foci | 64%–84% | GTR plus craniospinal XRT with posterior fossa boost |
Cerebellar liponeurocytoma | II | N/A | Hemispheres > vermis | Minimal heterogeneous enhancement; mottled areas of hyperintensity | N/A | GTR |
Hemangioblastoma | I | 0.80% | Hemispheres > vermis | Intense enhancement, flow voids; solid or cystic with mural nodule | >50% | GTR with close follow-up and screening for VHL |
Lhermitte-Duclos | I | N/A | Hemispheres | CT—low density with occasional calcifications; MR—“tiger stripe” nonenhancing | N/A | GTR with screening for Cowden syndrome |